Wedbush assumes Xometry at Outperform, sets $126 price target
Wedbush analyst Ygal Arounian assumed coverage of Xometry with an Outperform rating and set a price target of $126.

*this image is generated using AI for illustrative purposes only.
Wedbush analyst Ygal Arounian has assumed coverage of Xometry, assigning the stock an Outperform rating and establishing a price target of $126. Xometry trades on the NASDAQ under the ticker symbol XMTR.
Analyst Rating and Target
The Outperform rating suggests a positive outlook for the company's performance relative to the broader market. The newly set price target provides a specific valuation benchmark for investors monitoring the stock.
| Metric | Value |
|---|---|
| Rating | Outperform |
| Price Target | $126 |
| Exchange | NASDAQ |
| Ticker Symbol | XMTR |
What specific factors drove Wedbush's decision to assign an Outperform rating to Xometry?
How might Xometry's recent performance influence investor sentiment in the manufacturing sector?
What are the potential risks that could prevent Xometry from reaching the $126 price target?

























